IPP Bureau
Lonza and Moderna enter new agreement to double drug substance production for COVID-19 vaccine
By IPP Bureau - April 30, 2021
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
Cipla signs agreement with Merck for Molnupiravir
By IPP Bureau - April 29, 2021
Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19
Glenmark’s Ryaltris nasal spray approved in Europe
By IPP Bureau - April 27, 2021
In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark
Vaishali Pharma bags order worth US $270,000 from Afghanistan
By IPP Bureau - April 26, 2021
This achievement enables the company to strengthen its presence in the high growth market of South Asian countries
Govt. approves 25 manufacturing sites for Remdesivir production
By IPP Bureau - April 26, 2021
The production capacity is now ramped up to 90 lakh vials per month whereas earlier it was 40 lakh vials/month
Govt. waives off basic customs duty & health cess on oxygen equipment
By IPP Bureau - April 26, 2021
Apart from the above, it was also decided that Basic Customs Duty on import of COVID-19 vaccines be also exempted with immediate effect for a period of 3 months
Ports waive-off all charges for ships carrying oxygen
By IPP Bureau - April 26, 2021
Port chairpersons have been asked to personally supervise logistic operations to ensure unhindered movement of such consignments for berthing of such vessel on top priority in the port
Lonza will invest CHF 200 mn to construct manufacturing complex
By IPP Bureau - April 26, 2021
New manufacturing complex will occupy an overall footprint of approximately 2,000 square meter with six levels of manufacturing space
US to supply raw material for covishield vaccine
By IPP Bureau - April 26, 2021
The U.S. Development Finance Corporation is funding a substantial expansion of manufacturing capability for BioE, the vaccine manufacturer in India
Hester launches herbal veterinary product range
By IPP Bureau - April 26, 2021
In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries
Caplin Steriles gets USFDA approval
By IPP Bureau - April 23, 2021
The injection comes in multiple formats
Serum not contracted for complete production of COVID vaccine to centre
By IPP Bureau - April 23, 2021
These media reports are based on incorrect facts and are without any basis.
.jpeg "Prime Minister holds high level meeting on oxygen")
Prime Minister holds high level meeting on oxygen
By IPP Bureau - April 23, 2021
Against the present demand from 20 states of 6,785 MT/day of Liquid Medical Oxygen, the Government of India has from 21st April allocated 6,822 MT/day to these states
PM urges vaccine manufacturers to scale production capacity
By IPP Bureau - April 21, 2021
The country has constantly worked with the spirit of public-private partnership
Pharma and medical device to play a pivotal role: Gowda
By IPP Bureau - April 21, 2021
The Department of Pharmaceuticals launched the PLI scheme for promoting domestic manufacturing of bulk drugs, with a financial outlay of Rs. 6,940 crore across 53 APIs over 6 years
